Helicobacter pylori infection
Conditions
Interventions
observation group 1:The treatment lasted for 10 days, including vonoprazan 20mg twice a day, amoxicillin 1g three times a day
observation group 2:The treatment lasted for 10 days, including vonoprazan 20mg twice a day, amoxicillin 1g three times a day, furazolidone 100mg twice a day
observation group 3:The treatment lasted for 14 days, including vonoprazan 20mg twice a day, amoxicillin 1g three times a day
control group:Amoxicillin 1g twice a day, clarithromycin sustained-release tablet 0.5g twice a day, rabeprazole sodium enteric-soluble capsule 20mg twice a day, colloidal bismuth 0.3g twice a day. Pat
Sponsors
Xuzhou First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years, no gender limit; 2. The C13 breath test confirmed Helicobacter pylori infection; 3. Sign the informed consent and agree to follow the test requirements.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating patients; 2. Patients with other serious diseases, such as heart disease, serious liver and kidney diseases, malignant tumors, etc.; 3. Patients with mental disorders or severe neurosis; 4. Patients who are allergic to medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The condition of Helicobacter pylori (Hp) infection; | — |
Countries
China
Contacts
Public ContactChen Guangxia
Xuzhou First People's Hospital
Outcome results
None listed